Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

FRA/6HN stock hub

FRA/6HN has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/6HNis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.3B

Frankfurt Stock Exchange

Market data

Price

Recent price action with selectable time range.

FRA/6HNFRA/6HN

—

Loading chart…

In the news

Latest news · FRA/6HN

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E69.1

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-6.4

P25 n/aP50 n/aP75 n/a

ROIC-4

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/6HN market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

166

Groups with data

Currency

CNY

Showing 166 of 166 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Cayman Islands
Country code	DE
Employees	812
Employees Change	147%
Employees Change Percent	22.11
Enterprise value	EUR 1B
Exchange	Frankfurt Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	EUR 1.3B
Price	EUR 3.42
Price currency	EUR
Rev Per Employee	255,936.22x
Sic	2836
Symbol	fra/6HN
Website	https://www.everestmedicines.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-2.9%
EV Earnings	-28.5x
EV/FCF	-54.2x
EV/Sales	5.01x
FCF yield	-1.52%
Forward P/E	69.08x
P/B ratio	1.94x
P/S ratio	6.02x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-20.15%
EBITDA Margin	-12.37%
Gross margin	69.25%
Gross Profit	EUR 143.9M
Gross Profit Growth	99.24%
Gross Profit Growth Q	200.36%
Gross Profit Growth3 Y	55.06%
Gross Profit Growth5 Y	146.28%
Net Income	EUR -36.3M
Pretax Margin	-35.06%
Profit Margin	-17.45%
Profit Per Employee	EUR -44,653
ROA	-3.64
Roa5y	-8.77
ROCE	-5.6
ROE	-6.35
Roe5y	-13.08
ROIC	-3.95

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-35.49%
Cagr3y	28.28%
Cagr5y	-11.92%
Revenue Growth	141.51x
Revenue Growth Q	211.12x
Revenue Growth3 Y	59.76x
Revenue Growth5 Y	141.81x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.29
Assets	EUR 832.3M
Cash	EUR 332.6M
Current Assets	EUR 420.6M
Current Liabilities	EUR 86M
Debt	EUR 112.8M
Debt Equity	EUR 0.17
Debt FCF	EUR -5.92
Equity	EUR 645.8M
Interest Coverage	-14.78
Liabilities	EUR 186.5M
Long Term Assets	EUR 411.7M
Long Term Liabilities	EUR 100.5M
Net Cash	EUR 219.8M
Net Cash By Market Cap	EUR 17.57
Net Cash Growth	75.61%
Net Debt Equity	EUR -0.34
Tangible Book Value	EUR 391.2M
Tangible Book Value Per Share	EUR 1.11

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.89
Inventory Turnover	22.67
Net Working Capital	EUR 5.6M
Quick ratio	4.76
Working Capital	EUR 326.8M
Working Capital Turnover	EUR 0.11

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-4.84%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-35.47%
200-day SMA	5.14
3Y total return	111.11%
50-day SMA	3.93
50-day SMA vs 200-day SMA	50under200
5Y total return	-46.98%
All Time High	10.9
All Time High Change	-68.62%
All Time High Date	2021-02-15
All Time Low	0.77
All Time Low Change	346.48%
All Time Low Date	2022-10-31
ATR	0.08
Ch YTD	-15.35
High	3.42
High52	8.25
High52 Date	2025-07-24
High52ch	-58.55%
Low	3.42
Low52	3.42
Low52 Date	2026-05-08
Low52ch	0%
Ma50ch	-12.89%
Price vs 200-day SMA	-33.48%
RSI	29.21
RSI Monthly	42.62
RSI Weekly	35.64
Sharpe ratio	-0.56x
Sortino ratio	-0.7
Total Return	-4.84%
Tr YTD	-15.35
Tr1m	-22.27%
Tr1w	-6.56%
Tr3m	-18.57%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -41.9M
Operating margin	-20.15

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	262,334,708%
Net Borrowing	43,184,991
Shares Insiders	1.17%
Shares Institutions	17.73%
Shares Qo Q	6.8%
Shares Yo Y	4.84%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -35.1M
Average Volume	0x
Bv Per Share	1.84
CAPEX	EUR -7.8M
Ch1m	-22.27
Ch1w	-6.56
Ch1y	-35.47
Ch3m	-18.57
Ch3y	111.1
Ch5y	-46.98
Ch6m	-30.77
Change	-3.93%
Change From Open	0
Close	3.56
Days Gap	-3.93
Depreciation Amortization	16,547,154
Earnings Date	2026-03-26
EBIT	EUR -41.9M
EBITDA	EUR -25.7M
EPS	EUR -0.11
F Score	1
FCF	EUR -19.1M
FCF EV Yield	-1.84x
Financing CF	215,859,386
Fiscal Year End	December
Founded	2,017
Income Tax	EUR -36.6M
Investing CF	-84,350,252
Is Primary Listing	0
Last Earnings Date	2026-03-26
Last Report Date	2025-12-31
Ma150	4.52
Ma150ch	-24.34%
Ma20	3.89
Ma20ch	-12.06%
Net CF	116,887,983
Open	3.42
Ppne	81,857,235.1
Price Date	2026-05-08
Ptbv Ratio	3.2
Relative Volume	20x
Revenue	207,820,207x
SBC By Revenue	7.72x
Share Based Comp	16,046,211
Tax By Revenue	-17.61x
Tr6m	-30.77%
Z Score	4.79

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FRA/6HN pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/6HN stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/6HN?

Insider, institutional, and short-interest positioning.

Institutional ownership

+17.7%

Share of float held by funds and institutions

Insider ownership

+1.2%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+4.8%

Negative means the company is buying back shares.

Technical

FRA/6HN momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

29.2

Below 30: short-term oversold

Price vs 200-day MA

-33.5%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

-0.56

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/6HN

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/6HN stock rating?

fra/6HN is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/6HN analysis?

The full report lives at /stocks/fra/6HN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/6HN?

The latest report frames fra/6HN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/6HN page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.